REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 3 filers reported holding REATA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $827,609 | +4.5% | 8,117 | -6.8% | 0.00% | 0.0% |
Q1 2023 | $791,640 | +133.4% | 8,707 | -2.5% | 0.00% | +100.0% |
Q4 2022 | $339,137 | -2.0% | 8,927 | -35.3% | 0.00% | 0.0% |
Q3 2022 | $346,000 | -17.4% | 13,787 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $419,000 | -1.4% | 13,787 | +6.2% | 0.00% | 0.0% |
Q1 2022 | $425,000 | +24.3% | 12,987 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $342,000 | -74.9% | 12,987 | -4.1% | 0.00% | -66.7% |
Q3 2021 | $1,363,000 | -25.8% | 13,546 | +4.4% | 0.00% | 0.0% |
Q2 2021 | $1,836,000 | -43.2% | 12,976 | -60.0% | 0.00% | -50.0% |
Q1 2021 | $3,235,000 | -19.3% | 32,452 | +0.1% | 0.01% | -25.0% |
Q4 2020 | $4,009,000 | +37.2% | 32,432 | +8.2% | 0.01% | +14.3% |
Q3 2020 | $2,921,000 | -29.4% | 29,983 | +13.0% | 0.01% | -30.0% |
Q2 2020 | $4,138,000 | +187.0% | 26,523 | +165.4% | 0.01% | +150.0% |
Q1 2020 | $1,442,000 | -23.3% | 9,992 | +8.6% | 0.00% | -20.0% |
Q4 2019 | $1,881,000 | +173.8% | 9,202 | +7.5% | 0.01% | +150.0% |
Q3 2019 | $687,000 | -15.0% | 8,562 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $808,000 | +19.7% | 8,562 | +8.4% | 0.00% | 0.0% |
Q1 2019 | $675,000 | +58.1% | 7,902 | +3.8% | 0.00% | +100.0% |
Q4 2018 | $427,000 | -24.6% | 7,612 | +9.9% | 0.00% | 0.0% |
Q3 2018 | $566,000 | +133.9% | 6,926 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $242,000 | – | 6,926 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DekaBank Deutsche Girozentrale | 17,000 | $2,930 | 0.01% |
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 93,711 | $1,612 | 0.00% |
IFP Advisors, Inc | 300 | $51,708 | 0.00% |